VIP (Vasoactive Intestinal Peptide)

Source / Derivation:

VIP is a synthetic analog of the naturally occurring vasoactive intestinal peptide, a neuropeptide that regulates cardiovascular, gastrointestinal, and immune function. It is produced to replicate endogenous activity with enhanced stability and bioavailability. VIP has been studied for its systemic effects on vasodilation, immune modulation, and tissue repair.

VIP (Vasoactive Intestinal Peptide)

Mechanism of Action:

VIP binds to VPAC1 and VPAC2 receptors, promoting smooth muscle relaxation, vasodilation, and anti-inflammatory signaling. It also modulates immune cell function and supports cellular metabolism. Additionally, VIP may improve tissue oxygenation, organ function, and overall systemic homeostasis.

Clinical Relevance & Potential Outcomes:

Research suggests VIP may support enhanced vascular function, immune modulation, and tissue repair. It has potential applications in cardiovascular support, pulmonary therapy, and gastrointestinal health. Clinical studies indicate benefits in reducing inflammation, improving organ resilience, and promoting systemic wellness.

Intended Clinical Application:

VIP may be relevant for patients requiring vascular support, immune regulation, or enhanced tissue repair. It may also be considered in multi-system regenerative or supportive health strategies.

Formulation & Quality Specifications:

Delivered as a liquid prefilled pen
Purity: >98% (HPLC-validated)
Storage: 2–8 °C (refrigerated)
Documentation: Full CoA and MSDS available

Concentration:

Frequency:

Dosage (pen clicks):

Duration:

Notes:

5 mg/ml, total 3 ml, total 15 mg

Daily

1 month

VIP is used for immune modulation and inflammation control.